2025-09-09 - Analysis Report
Okay, let's analyze Colgate-Palmolive (CL) based on the provided data.

**Report on Colgate-Palmolive (CL)**

Colgate-Palmolive Co. is a global company that manufactures and markets household, health care, personal care, and veterinary products.

**1. Performance vs. S&P 500 (VOO)**

*   **CL Cumulative Return:** 12.92%
*   **VOO Cumulative Return:** 101.31%
*   **Deviation:** -88.39
*   **Relative Deviation:** 3.4 (Indicates current deviation is near the lower end of its historical range compared to VOO)

**Analysis:** CL has significantly underperformed the S&P 500 over the period considered. The relative deviation suggests that while the underperformance is substantial, it is not unusual compared to its historical fluctuations.

**Alpha, Beta Analysis Table**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2015-2017  | 13.0%   | 4.5%    | -16.0%  | 0.0   | 60.3   |
| 2016-2018  | -11.0%  | 65.2%   | -29.0%  | 0.1   | 47.6   |
| 2017-2019  | 7.0%    | 65.2%   | -22.0%  | 0.1   | 55.0   |
| 2018-2020  | 18.0%   | 65.2%   | -2.0%   | 0.6   | 68.3   |
| 2019-2021  | 30.0%   | 58.6%   | -19.0%  | 0.7   | 68.2   |
| 2020-2022  | 7.0%    | 69.0%   | 5.0%    | 0.7   | 63.0   |
| 2021-2023  | 6.0%    | 69.0%   | -12.0%  | 0.8   | 63.7   |
| 2022-2024  | 13.0%   | 69.0%   | -12.0%  | 0.8   | 72.7   |
| 2023-2025  | 0.0%    | 70.6%   | -53.0%  | 0.3   | 68.0   |

**Analysis:**

*   **CAGR:** Fluctuates, with recent years showing lower or moderate growth.
*   **MDD:** Relatively high Maximum Drawdown values suggest potential volatility.
*   **Alpha:** Mostly negative Alpha indicates underperformance compared to its benchmark (market).  The period 2020-2022 is a notable exception, showing positive alpha.
*   **Beta:** Low Beta values (close to 0) suggest low correlation with the market (less sensitive to market movements). The recent Beta values are slightly higher but still indicate relatively low volatility.
*   **Cap:** Market capitalization is relatively stable, around the 60-70 billion dollar range.

**2. Recent Stock Price Movement**

*   **Current Price:** 85.13
*   **Last Market Price:** 84.19 (Change: -1.1)
*   **5-Day Moving Average:** 84.02
*   **20-Day Moving Average:** 84.74
*   **60-Day Moving Average:** 87.22

**Analysis:** The stock price has decreased in the very recent trading session.  The 5-day moving average is below the 20-day moving average, which is below the 60-day moving average. This *could* indicate a short-term downward trend. The price drop in the Last Market suggests possible negative sentiment or event-driven selling.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 50.31 (Neutral)
*   **PPO:** 0.11 (Potentially bullish, but close to zero)
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (9 shares - Caution - MRI:0.33)
*   **20-Day Relative Deviation Change:** 3.4 (Short-term Increase)
*   **Expected Return:** -1027.5%

**Analysis:**

*   The Market Risk Indicator suggests a low-risk environment for the stock.
*   RSI is neutral, indicating no strong overbought or oversold condition.
*   PPO is close to zero, suggesting limited momentum.
*   The Hybrid Signal, despite being a "Buy" signal, suggests caution due to the MRI level.
*   The recent increase in relative deviation indicates improving short-term performance relative to the S&P 500.
*   **The extremely negative Expected Return is highly unusual and should be investigated further. This might be an error in the data or calculation.** It suggests a projected underperformance of over 1000% compared to the S&P 500 over a long-term investment horizon (2+ years).

**4. Recent News & Significant Events**

*   **Passive Income Opportunity:** Benzinga article highlights the potential for passive income through Colgate-Palmolive stock.
*   **AI Adoption:** Packaging Dive reports Colgate-Palmolive's adoption of AI for biomaterials development, indicating a focus on innovation.
*   **Market Overviews:** Investing.com articles provide general market context.
*   **Geopolitical Factors:** Trump's comments and Canadian trade data are potentially relevant macroeconomic factors.

**Analysis:** The news is a mix of company-specific positive developments (AI adoption, passive income potential) and general market/geopolitical information. The AI adoption news could be a long-term positive catalyst.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (2.10)
*   **Target Price:** 95.22 (Average)

**Analysis:** Analysts generally have a positive outlook on the stock, with a consensus rating of "Buy" and an average target price significantly above the current price.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-08-01 | 0.92  | 5.11 B$    |
| 2025-04-25 | 0.85  | 4.91 B$    |
| 2024-10-25 | 0.90  | 5.03 B$    |
| 2024-07-26 | 0.89  | 5.06 B$    |
| 2025-08-01 | 0.89  | 5.06 B$    |

**Analysis:** The company has shown consistent revenue in the range of $4.91B to $5.11B. EPS has been relatively stable, fluctuating between $0.85 and $0.92. The earnings data suggests consistent performance.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | $5.11B    | 60.06%        |
| 2025-03-31 | $4.91B    | 60.82%        |
| 2024-12-31 | $4.95B    | 60.30%        |
| 2024-09-30 | $5.03B    | 61.08%        |
| 2024-06-30 | $5.06B    | 60.62%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-06-30 | $0.70B    | 105.84%   |
| 2025-03-31 | $0.36B    | 190.08%   |
| 2024-12-31 | $0.21B    | 348.58%   |
| 2024-09-30 | $0.43B    | 169.43%   |
| 2024-06-30 | $0.12B    | 594.31%   |

**Analysis:**

*   **Revenue & Profit Margin:** Revenues are consistent, and profit margins are very high, indicating a strong ability to convert sales into profit.
*   **Equity & ROE:** Equity has fluctuated. ROE is extremely high, potentially indicating aggressive financial leverage or accounting anomalies. *The high ROE warrants further investigation to ensure its sustainability.*

**7. Overall Summary**

Colgate-Palmolive (CL) is a stable, mature company with consistent revenue and high profit margins. Analyst opinions are positive. However, there are several concerning points:

*   **Significant Underperformance vs. S&P 500:** CL has significantly underperformed the market.
*   **Extremely Negative Expected Return:** *This is a red flag and requires verification.*
*   **High ROE:** *The sustainability of the high ROE needs further analysis.*
*   **Recent Price Decline:** The stock price has recently declined, with moving averages indicating a potential short-term downward trend.

**Recommendation:**

Given the mixed signals, a neutral stance is warranted. The company's financial stability and positive analyst ratings are counterbalanced by the significant underperformance, the questionable "Expected Return" figure, and the fluctuating equity/high ROE. Further investigation into the long-term growth prospects, sustainability of ROE, and the "Expected Return" calculation is crucial before making any investment decision.
